BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29489027)

  • 41. Frequent amplification of receptor tyrosine kinase genes in welldifferentiated/ dedifferentiated liposarcoma.
    Asano N; Yoshida A; Mitani S; Kobayashi E; Shiotani B; Komiyama M; Fujimoto H; Chuman H; Morioka H; Matsumoto M; Nakamura M; Kubo T; Kato M; Kohno T; Kawai A; Kondo T; Ichikawa H
    Oncotarget; 2017 Feb; 8(8):12941-12952. PubMed ID: 28099935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterologous Liposarcomatous Differentiation in Malignant Phyllodes Tumor is Histologically Similar but Immunohistochemically and Molecularly Distinct from Well-differentiated Liposarcoma of Soft Tissue.
    Inyang A; Thomas DG; Jorns J
    Breast J; 2016 May; 22(3):282-6. PubMed ID: 26843318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sclerosing poorly differentiated liposarcoma: clinicopathological, immunohistochemical and molecular analysis of a distinct morphological subtype of lipomatous tumour of soft tissue.
    Suster S; Morrison C
    Histopathology; 2008 Feb; 52(3):283-93. PubMed ID: 18269578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
    Longhi A; Bielack SS; Grimer R; Whelan J; Windhager R; Leithner A; Gronchi A; Biau D; Jutte P; Krieg AH; Klenke FM; Grignani G; Donati DM; Capanna R; Casanova J; Gerrand C; Bisogno G; Hecker-Nolting S; De Lisa M; D'Ambrosio L; Willegger M; Scoccianti G; Ferrari S
    Eur J Cancer; 2017 Mar; 74():9-16. PubMed ID: 28167373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cutaneous and subcutaneous pleomorphic liposarcoma: a clinicopathologic study of 29 cases with evaluation of MDM2 gene amplification in 26.
    Gardner JM; Dandekar M; Thomas D; Goldblum JR; Weiss SW; Billings SD; Lucas DR; McHugh JB; Patel RM
    Am J Surg Pathol; 2012 Jul; 36(7):1047-51. PubMed ID: 22472959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subcutaneous extraskeletal osteosarcoma of the forearm: a case report and review of the literature.
    Healy C; Kahn LB; Kenan S
    Skeletal Radiol; 2016 Sep; 45(9):1307-11. PubMed ID: 27357312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene amplification and tumor grading in parosteal osteosarcoma.
    Chen PC; Yen CC; Hung GY; Pan CC; Chen WM
    J Chin Med Assoc; 2019 Dec; 82(12):889-894. PubMed ID: 31634336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours.
    Dei Tos AP; Doglioni C; Piccinin S; Sciot R; Furlanetto A; Boiocchi M; Dal Cin P; Maestro R; Fletcher CD; Tallini G
    J Pathol; 2000 Apr; 190(5):531-6. PubMed ID: 10727978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
    Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T
    Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
    Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Primary extraskeletal osteosarcoma: a clinicopathological study of ten cases].
    Huang HJ; Jiang QJ; Fan DG; Chen XY; Zhong DR
    Zhonghua Bing Li Xue Za Zhi; 2021 Jan; 50(1):44-48. PubMed ID: 33396986
    [No Abstract]   [Full Text] [Related]  

  • 53. Extraskeletal osteosarcoma in Norway, between 1975 and 2009, and a brief review of the literature.
    Berner K; Bjerkehagen B; Bruland ØS; Berner A
    Anticancer Res; 2015 Apr; 35(4):2129-40. PubMed ID: 25862869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma.
    Heng M; Gupta A; Chung PW; Healey JH; Vaynrub M; Rose PS; Houdek MT; Lin PP; Bishop AJ; Hornicek FJ; Chen YL; Lozano-Calderon S; Holt GE; Han I; Biau D; Niu X; Bernthal NM; Ferguson PC; Wunder JS; ;
    Eur J Cancer; 2020 Jan; 125():130-141. PubMed ID: 31806415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MDM2/CDK4 gene amplification in large/deep-seated 'lipomas': incidence, predictors and clinical significance.
    Wong DD; Low IC; Peverall J; Robbins PD; Spagnolo DV; Nairn R; Carey-Smith RL; Wood D
    Pathology; 2016 Apr; 48(3):203-9. PubMed ID: 27020493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extraskeletal osteosarcoma arising in the subcutaneous tissue of the lower leg: A case report and literature review.
    Tamura T; Suzuki K; Yasuda T; Nogami S; Watanabe K; Kanamori M; Kimura T
    Mol Clin Oncol; 2018 Sep; 9(3):287-292. PubMed ID: 30112173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parosteal osteoliposarcoma: a new bone tumor (from imaging to immunophenotype).
    Larousserie F; Chen X; Ding Y; Kreshak J; Cocchi S; Huang X; Niu X; Alberghini M; Vanel D
    Eur J Radiol; 2013 Dec; 82(12):2149-53. PubMed ID: 22178310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma.
    Thampi S; Matthay KK; Boscardin WJ; Goldsby R; DuBois SG
    Sarcoma; 2014; 2014():902620. PubMed ID: 25294959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MDM2 gene amplification in metastatic osteosarcoma.
    Ladanyi M; Cha C; Lewis R; Jhanwar SC; Huvos AG; Healey JH
    Cancer Res; 1993 Jan; 53(1):16-8. PubMed ID: 8416741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.
    Limbach AL; Lingen MW; McElherne J; Mashek H; Fitzpatrick C; Hyjek E; Mostofi R; Cipriani NA
    Head Neck Pathol; 2020 Dec; 14(4):889-898. PubMed ID: 32026294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.